Reflect Scientific, Inc. (RSCF)
0.0464
0.00 (0.00%)
USD |
OTCM |
Aug 28, 16:00
Reflect Scientific Free Cash Flow : 0.1773M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1773M |
| March 31, 2026 | 0.5654M |
| December 31, 2025 | 0.8619M |
| September 30, 2025 | 0.6471M |
| June 30, 2025 | 0.1967M |
| March 31, 2025 | -0.0209M |
| December 31, 2024 | -0.2635M |
| September 30, 2024 | -0.309M |
| June 30, 2024 | -0.3061M |
| March 31, 2024 | -0.0996M |
| December 31, 2023 | -0.104M |
| September 30, 2023 | 0.0147M |
| June 30, 2023 | 0.161M |
| March 31, 2023 | -0.3805M |
| December 31, 2022 | -0.092M |
| September 30, 2022 | 0.1807M |
| June 30, 2022 | 0.19M |
| March 31, 2022 | 0.6727M |
| December 31, 2021 | 0.8314M |
| September 30, 2021 | 0.5737M |
| June 30, 2021 | 0.4733M |
| March 31, 2021 | 0.1917M |
| December 31, 2020 | -0.0252M |
| September 30, 2020 | 0.0008M |
| June 30, 2020 | 0.2669M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.3479M |
| December 31, 2019 | 0.3359M |
| September 30, 2019 | 0.2903M |
| June 30, 2019 | 0.0632M |
| March 31, 2019 | 0.014M |
| December 31, 2018 | -0.0146M |
| September 30, 2018 | -0.0069M |
| June 30, 2018 | -0.0318M |
| March 31, 2018 | 0.0091M |
| December 31, 2017 | -0.0281M |
| September 30, 2017 | -0.1395M |
| June 30, 2017 | -0.0586M |
| March 31, 2017 | 0.058M |
| December 31, 2016 | -0.0187M |
| September 30, 2016 | -0.015M |
| June 30, 2016 | -0.0606M |
| March 31, 2016 | -0.1714M |
| December 31, 2015 | 0.0319M |
| September 30, 2015 | 0.104M |
| June 30, 2015 | 0.0332M |
| March 31, 2015 | 0.1281M |
| December 31, 2014 | 0.1098M |
| September 30, 2014 | 0.0957M |
| June 30, 2014 | 0.1092M |
| March 31, 2014 | 0.0937M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| West Pharmaceutical Services, Inc. | 436.90M |
| Agilent Technologies, Inc. | 1.267B |
| Anika Therapeutics, Inc. | 0.562M |
| Bio-Rad Laboratories, Inc. | 353.10M |
| Bruker Corp. | 93.90M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -0.1674M |
| Free Cash Flow Per Share (Quarterly) | -0.002 |
| Free Cash Flow to Equity (Quarterly) | -0.1417M |
| Free Cash Flow to Firm (Quarterly) | -0.1674M |
| Free Cash Flow Yield | 4.46% |